Results 111 to 120 of about 2,601 (150)

[Transmembrane protein 16A--a new target for the treatment of airway inflammatory diseases]. [PDF]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
Luo Q, Xu N, Tan X.
europepmc   +1 more source

[Extracellular matrix materials and tissue regeneration and repair]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Zhao L, Xie H.
europepmc   +1 more source

[Research progress on the pathogenesis and treatment strategies of Duchenne muscular dystrophy]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Ye YZ, Wu LW.
europepmc   +1 more source

[Development and Validation of a Risk Prediction Model for Secondary Pulmonary Infarction in Elderly Patients With Acute Pulmonary Embolism]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Chen S, Weng M, Lü Y, Jiang Y, Pang Y.
europepmc   +1 more source

骨髓间充质干细胞诱导分化为心肌细胞及其内向整流钾电流特征 [PDF]

, 2005

core  

[Research progress on toxic shock syndrome due to group A <i>Streptococcus</i> infection in children]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Wang HY, Zhou W, Huang LS.
europepmc   +1 more source

[Systemic lupus erythematosus complicated by autoimmune nodopathy: A case report]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Wei C, Yang Y, Zhao X, Liu X, Jia Y.
europepmc   +1 more source

[Overwork damages myocardial energy metabolism homeostasis in mice]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Cui J, Lai R, Chen S, Qu S, Liao Y, Ma X, Li Y.   +6 more
europepmc   +1 more source

[β‑blockers after percutaneous coronary intervention does not reduce risks of all-cause mortality or major adverse cardiovascular events in patients with stable coronary artery disease]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Gao X, Xiao J, Feng N, Guo C, Cao L, Zhang C, Zhang Y, Han T.   +7 more
europepmc   +1 more source

[Clinical efficacy and safety of rituximab in treating renal injury in primary Sjögren syndrome]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Zhao Y, Ni M, Li X, Wang B, Cheng G, He J, Jin Y.   +6 more
europepmc   +1 more source